These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1623814)

  • 1. Etidronate for vertebral osteoporosis after the menopause.
    Drug Ther Bull; 1992 Jun; 30(12):45-6. PubMed ID: 1623814
    [No Abstract]   [Full Text] [Related]  

  • 2. Critical drug appraisal: etidronate intermittent cyclic therapy for postmenopausal osteoporosis.
    Miller PD
    Br J Clin Pract; 1996; 50(1):23-31. PubMed ID: 8729598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis.
    Storm T; Kollerup G; Thamsborg G; Genant HK; Sørensen OH
    J Rheumatol; 1996 Sep; 23(9):1560-4. PubMed ID: 8877926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etidronate for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 1990 Dec; 32(833):111-2. PubMed ID: 2123282
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial.
    Kushida K; Fukunaga M; Kishimoto H; Shiraki M; Itabashi A; Inoue T; Kaneda K; Morii H; Nawata H; Yamamoto K; Ohashi Y; Orimo H
    J Bone Miner Metab; 2004; 22(5):469-78. PubMed ID: 15316868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of postmenopausal osteoporosis with etidronate.
    Heyneman CA
    Ann Pharmacother; 1993 Oct; 27(10):1200-1. PubMed ID: 8251688
    [No Abstract]   [Full Text] [Related]  

  • 7. Didronel PMO.
    Stone M
    Br J Hosp Med; 1993 Feb 17-Mar 2; 49(4):275-7. PubMed ID: 8443628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease.
    Arase Y; Suzuki F; Suzuki Y; Akuta N; Kobayashi M; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Ikeda K; Kumada H
    J Med Virol; 2008 Jul; 80(7):1302-7. PubMed ID: 18461628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteoporosis in menopause: prevention and management].
    Paran D; Elkayam O; Yaron M; Caspi D
    Harefuah; 1999 Mar; 136(6):483-8. PubMed ID: 10914269
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical osteomalacia after 2 year etidronate intermittent cyclic administration in osteoporosis.
    Thomas T; Lafage MH; Alexandre C
    J Rheumatol; 1995 Nov; 22(11):2183-5. PubMed ID: 8596168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
    Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of postmenopausal osteoporosis with etidronate].
    Terranova R; Luca S
    Minerva Med; 1999 Mar; 90(3):85-90. PubMed ID: 10432959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclical etidronate treatment of osteoporosis.
    N Engl J Med; 1990 Dec; 323(23):1633-5. PubMed ID: 2122254
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of alternative treatments for women with osteoporosis in Canada.
    Goeree R; Blackhouse G; Adachi J
    Curr Med Res Opin; 2006 Jul; 22(7):1425-36. PubMed ID: 16834841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risedronate reduces the risk of first vertebral fracture in osteoporotic women.
    Heaney RP; Zizic TM; Fogelman I; Olszynski WP; Geusens P; Kasibhatla C; Alsayed N; Isaia G; Davie MW; Chesnut CH
    Osteoporos Int; 2002; 13(6):501-5. PubMed ID: 12107665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent cyclic etidronate treatment of postmenopausal osteoporosis.
    Sternberg JL
    Am J Med; 1995 Sep; 99(3):333-4. PubMed ID: 7653501
    [No Abstract]   [Full Text] [Related]  

  • 17. A new option for treating osteoporosis.
    Riggs BL
    N Engl J Med; 1990 Jul; 323(2):124-5. PubMed ID: 2113610
    [No Abstract]   [Full Text] [Related]  

  • 18. 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.
    Sebaldt RJ; Ioannidis G; Adachi JD; Bensen WG; Bianchi F; Cividino A; Gordon M; Kaminska E; Scocchia T; Petrie A; Stephenson GF; Goldsmith CH
    J Rheumatol; 1999 Jul; 26(7):1545-9. PubMed ID: 10405943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis.
    Harrington JT; Ste-Marie LG; Brandi ML; Civitelli R; Fardellone P; Grauer A; Barton I; Boonen S
    Calcif Tissue Int; 2004 Feb; 74(2):129-35. PubMed ID: 14648009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis.
    Loeliger EA
    Am J Med; 1995 Aug; 99(2):225-6. PubMed ID: 7677912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.